Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1

Status

Unknown 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

pegylated granulocyte colony-stimulating factor 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Breastcancer × Clear all
NCT03121248 2023-12-22

HAI-5-III

University Hospital, Ghent

Phase NA Active not recruiting
144 enrolled
Breast

Breastcancer

NCT02996240 2021-03-17

Breast, Omega 3 Free Fatty Acid, Ph 0

The University of Texas Health Science Center at San Antonio

Phase NA Completed
21 enrolled
Breast

Breastcancer

NCT02975128 2020-05-29

BLES

Radboud University Medical Center

Phase NA Terminated
22 enrolled
Breast

Breastcancer

NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Peking University

Phase 4 Completed
240 enrolled
Breast

Breastcancer

NCT02967146 2017-01-05

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Samsung Medical Center

Phase 3 Unknown
170 enrolled
Breast

Breastcancer

NCT02997384 2016-12-20

RIVIERA

Gustave Roussy, Cancer Campus, Grand Paris

Unknown
600 enrolled
Breast

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡